Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 161 - 170 of 223 for bayer. (0.12 seconds)

CBT 200 Down 19 Points. More details...
CBT 200 Drops 17 Points. More details...
CBT 200 Drops 44 Points. More details...
Price Declines Bring Sector Into Buy Range. More details...
Any Blockbuster Announcements Likely?. More details...
CBT 200 Takes A Header. More details...
No Real Breakthrough But A Big Shift. More details...
CBT 200 Drops 3.3%. More details...
CBT 200 Drops Another 1%. More details...
Company Develops Antibiotics. More details...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital